医学
结直肠癌
佐剂
辅助化疗
化疗
疾病
阶段(地层学)
肿瘤科
癌症
内科学
重症监护医学
乳腺癌
生物
古生物学
作者
Christine Brezden-Masley,Chanele K. Polenz
标识
DOI:10.1016/j.soc.2013.09.009
摘要
Colorectal cancer is one of the most commonly diagnosed cancers in men and women in the developed world. Although surgery is the foundation of curative treatment, adjuvant chemotherapy also improves overall and disease-free survival in high-risk stage II and all stage III patients. Research strongly suggests that the timing from surgery to adjuvant chemotherapy is critical, because delays to the start of treatment significantly affect patient outcomes. Both clinical and systemic barriers, such as postoperative complications and institutional wait times, challenge the timely administration of adjuvant chemotherapy. Further research investigating solutions to overcome these barriers is needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI